Half-Year Trading Update

Sales growth of more than 900%, debt-free andsignificantly cashflow positiveDemand for COVID-19 test expected to continue into 2021 Paris, France and Camberley, UK – 13 July 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an unaudited trading update for the six months ended 30 June 2020. http://novacyt.com/wp-content/uploads/2020/07/Novacyt-H1-2020-Trading-Update-13-07-2020-ENGLISH.pdf

Visit Page

Publication du rapport annuel

Paris, France et Camberley, Royaume-Uni – 30 juin 2020 – Novacyt (ALTERNEXT : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique, annonce que le rapport annuel et les comptes du Groupe (“rapport annuel”) pour l’exercice clos le 31 décembre 2019 ont été publiés et mis en ligne sur le site internet du Groupe.

Visit Page

Publication of Annual Report

Paris, France and Camberley, UK – 30 June 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company’s Annual Report and Accounts (“Annual Report”) for the year ended 31 December 2019 has been published and uploaded to the Company’s website. The Annual Report will be posted to

Visit Page